Replies to post #149961 on Rivulet Media Inc (fka RIVU)

[sizzleweed]

The news yesterday of the patent filing

Regen BioPharma Inc. Files Patent Application for Treatment of Myelodysplastic Syndrome Utilizing Gene Silencing TherapyFont size: A | A | A
8:30 AM ET 3/3/15 | Marketwired
Regen BioPharma Inc. (OTCBB: RGBP) (OTC PINK: RGBP) announced today the filing of patent application # 14,572/574 covering methods, compositions, and protocols for the treatment of myelodysplastic syndrome by gene silencing using Regen's proprietary siRNA therapeutic sequences platform.